P
Pilly Chillo
Researcher at Muhimbili University of Health and Allied Sciences
Publications - 28
Citations - 257
Pilly Chillo is an academic researcher from Muhimbili University of Health and Allied Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 15 publications receiving 121 citations. Previous affiliations of Pilly Chillo include University of Bergen.
Papers
More filters
Journal ArticleDOI
Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania.
TL;DR: Cardiac abnormalities are common in HIV-infected patients, particularly when they present with symptoms, and the most common diagnosis was pericardial effusion present in 41.2% of the patients.
Journal ArticleDOI
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
Ganesan Karthikeyan,Stuart J. Connolly,Mpiko Ntsekhe,Alexander P. Benz,Sumathy Rangarajan,Gayle Lewis,Yan Yun,Sanjib Sharma,Fathi A. Maklady,Alaa Eldin Elghamrawy,Khawar Kazmi,Tantchou T J Cabral,Hu Dayi,Ma Changsheng,Bernard Gitura,Alvaro Avezum,Liesl Zühlke,Peter Lwabi,Abraham Haileamlak,Okechukwu S Ogah,Pilly Chillo,Maria Paniagua,Ahmed Elsayed,Antonio L. Dans,Lillian Gondwe-Chunda,Onkabetse Julia Molefe-Baikai,Jesus A Gonzalez-Hermosillo,James Hakim,Albertino Damasceno,Emmanuel R Kamanzi,John Musuku,Kairat Davletov,Katherine Connolly,Bongani M. Mayosi,Salim Yusuf,Invictus Investigators +35 more
TL;DR: INVICTUS is the largest program of clinical research focused on a neglected cardiovascular disease and will provide new information on the clinical course of patients with RHD, and approaches to anticoagulation in those with concomitant AF.
letters-and-commentsDOI
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Stuart J. Connolly,Ganesan Karthikeyan,Mpiko Ntsekhe,Abraham Haileamlak,Armed El Sayed,A. El Ghamrawy,Albertino Damasceno,Alvaro Avezum,Antonio L. Dans,Bernard Gitura,Dayi Hu,Emmanuel R Kamanzi,Fathi A. Maklady,Golden T Fana,J. Gonzalez-Hermosillo,John Musuku,Khawar Kazmi,Liesl Zühlke,Lillian Gondwe,Changsheng Ma,M.J Paniagua,Okechukwu S Ogah,Onkabetse Julia Molefe-Baikai,Peter Lwabi,Pilly Chillo,Sanjib Sharma,Tantchou Tchoumi Jacques Cabral,Wadea Tarhuni,Alexander P Benz,Martin van Eikels,Amy Krol,Divya Pattath,Kumar Balasubramanian,Sumathy Rangarajan,Chinthanie Ramasundarahettige,Bongani M. Mayosi,Salim Yusuf +36 more
TL;DR: Among patients with rheumatic heart disease-associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy, without a higher rate of bleeding.
Journal ArticleDOI
Early Mortality and Associated Factors among Patients with Stroke Admitted to a Large Teaching Hospital in Tanzania
TL;DR: Investigating correlates and predictors of 30-day mortality in stroke patients in urban Tanzania found poststroke mortality rates were high and many deaths were potentially preventable.
Journal ArticleDOI
Association between body fat composition and blood pressure level among secondary school adolescents in Dar es Salaam, Tanzania
Brighton Mushengezi,Pilly Chillo +1 more
TL;DR: Body mass index predicts BP level better than body fat composition and should be used as a measure of increased risk for hypertension among adolescents, according to World Health Organization definitions.